The brachytherapy devices market size has grown strongly in recent years. It will grow from $0.8 billion in 2025 to $0.85 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to limited availability of brachytherapy devices, reliance on low dose rate (ldr) treatments, increasing incidence of prostate and cervical cancers, slow adoption of automated afterloaders, constrained oncology infrastructure in emerging regions.
The brachytherapy devices market size is expected to see strong growth in the next few years. It will grow to $1.1 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to technological advancements in hdr and pdr brachytherapy, growth of specialty cancer clinics, rising investment in oncology healthcare, integration of ai and digital planning software, expanding awareness of brachytherapy benefits among clinicians. Major trends in the forecast period include rising adoption of high dose rate (hdr) brachytherapy, increasing use of minimally invasive brachytherapy procedures, expansion of cancer treatment centers and specialty clinics, integration of treatment planning software and qa devices, growing focus on patient safety and precision radiation delivery.
The increasing prevalence of cancer is expected to propel the growth of the brachytherapy devices market going forward. Cancer is a complex group of diseases characterized by uncontrolled cell growth and the potential to spread to other parts of the body. The rising prevalence of cancer is attributed to factors such as population aging, lifestyle changes, genetic predispositions, and environmental exposures. Brachytherapy devices provide substantial benefits to cancer patients by delivering targeted radiation directly to tumors, maximizing treatment effectiveness while minimizing damage to surrounding healthy tissue. This targeted approach enhances therapeutic efficacy, reduces side effects, shortens treatment duration, and lowers the risk of cancer recurrence, ultimately improving patient outcomes and quality of life. For instance, in August 2024, according to Macmillan Cancer Support, a UK-based organization, more than 3 million people in the UK were living with cancer in 2024, with projections indicating an increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing prevalence of cancer is driving the growth of the brachytherapy devices market.
Leading companies operating in the brachytherapy devices market are focusing on developing innovative solutions, such as advanced brachytherapy machines, to support patients requiring specialized cancer care. Advanced brachytherapy machines are designed to deliver internal radiation therapy with high precision, safety, and effectiveness by targeting cancerous tissue while minimizing exposure to surrounding healthy structures. For example, in June 2024, AIIMS Nagpur, an India-based medical institute, launched a state-of-the-art brachytherapy machine to improve the accuracy of cancer treatment. This technology enables localized radiation delivery, enhances treatment outcomes, and reduces damage to healthy tissue by providing controlled and precise radiation therapy.
In October 2023, Elekta, a Sweden-based neuroscience company, acquired the Xoft business from iCAD Inc. for an undisclosed amount. With this acquisition, Elekta aims to strengthen its brachytherapy portfolio and provide improved treatment outcomes for cancer patients. iCAD Inc. is a US-based manufacturer of brachytherapy devices.
Major companies operating in the brachytherapy devices market are Siemens Healthineers AG, Becton Dickinson and Company, GE HealthCare Technologies Inc., Boston Scientific Corporation, Koninklijke Philips N.V., Varian Medical Systems Inc., Carl Zeiss Meditec AG, Elekta AB, Hologic Inc., Mirion Technologies Inc., Accuray Inc., Eckert & Ziegler BEBIG S.A., Theragenics Corporation, Sensus Healthcare Inc., Aetna Inc., CIVCO Medical Solutions, iCAD Inc., IsoRay Inc., BEBIG Medical GmbH, IsoAid L.L.C.
North America was the largest region in the brachytherapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the brachytherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the brachytherapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the brachytherapy devices market by increasing the cost of imported afterloaders, applicators, and radiation sources. Segments such as remote afterloaders and high-precision applicators are most impacted, with regions like Asia-Pacific and Europe experiencing elevated import duties. This has led to higher production costs and delays in device availability. On the positive side, tariffs encourage local manufacturing, innovation in cost-effective device production, and development of domestic supply chains.
The brachytherapy devices market research report is one of a series of new reports that provides brachytherapy devices market statistics, including brachytherapy devices industry global market size, regional shares, competitors with a brachytherapy devices market share, detailed brachytherapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the brachytherapy devices industry. This brachytherapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Brachytherapy devices are specialized tools used to deliver internal radiation directly to or near cancerous tumors. They allow high-dose radiation treatment with minimal damage to surrounding healthy tissue, making them highly effective for cancers that are difficult to treat with external radiation.
The key product types of brachytherapy devices include brachytherapy afterloaders, brachytherapy applicators, and others. Brachytherapy afterloaders are automated systems designed to insert and withdraw radioactive sources during brachytherapy procedures, ensuring accurate dose delivery. The major indications include prostate cancer, breast cancer, cervical cancer, skin cancer, and others, with dose rates such as high-dose-rate (HDR), low-dose-rate (LDR), and pulse-dose-rate (PDR) brachytherapy. These devices are used by end users including hospitals, specialty clinics, and others.
The brachytherapy devices market consists of sales of applicators, catheters, needles, and seed implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The brachytherapy devices market size is expected to see strong growth in the next few years. It will grow to $1.1 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to technological advancements in hdr and pdr brachytherapy, growth of specialty cancer clinics, rising investment in oncology healthcare, integration of ai and digital planning software, expanding awareness of brachytherapy benefits among clinicians. Major trends in the forecast period include rising adoption of high dose rate (hdr) brachytherapy, increasing use of minimally invasive brachytherapy procedures, expansion of cancer treatment centers and specialty clinics, integration of treatment planning software and qa devices, growing focus on patient safety and precision radiation delivery.
The increasing prevalence of cancer is expected to propel the growth of the brachytherapy devices market going forward. Cancer is a complex group of diseases characterized by uncontrolled cell growth and the potential to spread to other parts of the body. The rising prevalence of cancer is attributed to factors such as population aging, lifestyle changes, genetic predispositions, and environmental exposures. Brachytherapy devices provide substantial benefits to cancer patients by delivering targeted radiation directly to tumors, maximizing treatment effectiveness while minimizing damage to surrounding healthy tissue. This targeted approach enhances therapeutic efficacy, reduces side effects, shortens treatment duration, and lowers the risk of cancer recurrence, ultimately improving patient outcomes and quality of life. For instance, in August 2024, according to Macmillan Cancer Support, a UK-based organization, more than 3 million people in the UK were living with cancer in 2024, with projections indicating an increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing prevalence of cancer is driving the growth of the brachytherapy devices market.
Leading companies operating in the brachytherapy devices market are focusing on developing innovative solutions, such as advanced brachytherapy machines, to support patients requiring specialized cancer care. Advanced brachytherapy machines are designed to deliver internal radiation therapy with high precision, safety, and effectiveness by targeting cancerous tissue while minimizing exposure to surrounding healthy structures. For example, in June 2024, AIIMS Nagpur, an India-based medical institute, launched a state-of-the-art brachytherapy machine to improve the accuracy of cancer treatment. This technology enables localized radiation delivery, enhances treatment outcomes, and reduces damage to healthy tissue by providing controlled and precise radiation therapy.
In October 2023, Elekta, a Sweden-based neuroscience company, acquired the Xoft business from iCAD Inc. for an undisclosed amount. With this acquisition, Elekta aims to strengthen its brachytherapy portfolio and provide improved treatment outcomes for cancer patients. iCAD Inc. is a US-based manufacturer of brachytherapy devices.
Major companies operating in the brachytherapy devices market are Siemens Healthineers AG, Becton Dickinson and Company, GE HealthCare Technologies Inc., Boston Scientific Corporation, Koninklijke Philips N.V., Varian Medical Systems Inc., Carl Zeiss Meditec AG, Elekta AB, Hologic Inc., Mirion Technologies Inc., Accuray Inc., Eckert & Ziegler BEBIG S.A., Theragenics Corporation, Sensus Healthcare Inc., Aetna Inc., CIVCO Medical Solutions, iCAD Inc., IsoRay Inc., BEBIG Medical GmbH, IsoAid L.L.C.
North America was the largest region in the brachytherapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the brachytherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the brachytherapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the brachytherapy devices market by increasing the cost of imported afterloaders, applicators, and radiation sources. Segments such as remote afterloaders and high-precision applicators are most impacted, with regions like Asia-Pacific and Europe experiencing elevated import duties. This has led to higher production costs and delays in device availability. On the positive side, tariffs encourage local manufacturing, innovation in cost-effective device production, and development of domestic supply chains.
The brachytherapy devices market research report is one of a series of new reports that provides brachytherapy devices market statistics, including brachytherapy devices industry global market size, regional shares, competitors with a brachytherapy devices market share, detailed brachytherapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the brachytherapy devices industry. This brachytherapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Brachytherapy devices are specialized tools used to deliver internal radiation directly to or near cancerous tumors. They allow high-dose radiation treatment with minimal damage to surrounding healthy tissue, making them highly effective for cancers that are difficult to treat with external radiation.
The key product types of brachytherapy devices include brachytherapy afterloaders, brachytherapy applicators, and others. Brachytherapy afterloaders are automated systems designed to insert and withdraw radioactive sources during brachytherapy procedures, ensuring accurate dose delivery. The major indications include prostate cancer, breast cancer, cervical cancer, skin cancer, and others, with dose rates such as high-dose-rate (HDR), low-dose-rate (LDR), and pulse-dose-rate (PDR) brachytherapy. These devices are used by end users including hospitals, specialty clinics, and others.
The brachytherapy devices market consists of sales of applicators, catheters, needles, and seed implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Brachytherapy Devices Market Characteristics
3. Brachytherapy Devices Market Supply Chain Analysis
4. Global Brachytherapy Devices Market Trends and Strategies
5. Brachytherapy Devices Market Analysis of End Use Industries
7. Global Brachytherapy Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Brachytherapy Devices Total Addressable Market (TAM) Analysis for the Market
9. Brachytherapy Devices Market Segmentation
10. Brachytherapy Devices Market Regional and Country Analysis
11. Asia-Pacific Brachytherapy Devices Market
12. China Brachytherapy Devices Market
13. India Brachytherapy Devices Market
14. Japan Brachytherapy Devices Market
15. Australia Brachytherapy Devices Market
16. Indonesia Brachytherapy Devices Market
17. South Korea Brachytherapy Devices Market
18. Taiwan Brachytherapy Devices Market
19. South East Asia Brachytherapy Devices Market
20. Western Europe Brachytherapy Devices Market
21. UK Brachytherapy Devices Market
22. Germany Brachytherapy Devices Market
23. France Brachytherapy Devices Market
24. Italy Brachytherapy Devices Market
25. Spain Brachytherapy Devices Market
26. Eastern Europe Brachytherapy Devices Market
27. Russia Brachytherapy Devices Market
28. North America Brachytherapy Devices Market
29. USA Brachytherapy Devices Market
30. Canada Brachytherapy Devices Market
31. South America Brachytherapy Devices Market
32. Brazil Brachytherapy Devices Market
33. Middle East Brachytherapy Devices Market
34. Africa Brachytherapy Devices Market
36. Brachytherapy Devices Market Competitive Landscape and Company Profiles
37. Brachytherapy Devices Market Other Major and Innovative Companies
40. Brachytherapy Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Brachytherapy Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses brachytherapy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for brachytherapy devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The brachytherapy devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Brachytherapy Afterloaders; Brachytherapy Applicators; Other Product Types2) By Indications: Prostate Cancer; Breast Cancer; Cervical Cancer; Skin Cancer; Other Indications
3) By Dose Rate: High Dose Rate (HDR) Brachytherapy; Low Dose Rate (LDR) Brachytherapy; Pulse Dose Rate (PDR) Brachytherapy
4) By End-User: Hospitals; Specialty Clinics; Other End-Users
Subsegments:
1) By Brachytherapy Afterloaders: Remote Afterloaders; Manual Afterloaders2) By Brachytherapy Applicators: Intravaginal Applicators; Interstitial Applicators; Intracavitary Applicators
3) By Other Product Types: Brachytherapy Seeds; Treatment Planning Software; Quality Assurance Devices
Companies Mentioned: Siemens Healthineers AG; Becton Dickinson and Company; GE HealthCare Technologies Inc.; Boston Scientific Corporation; Koninklijke Philips N.V.; Varian Medical Systems Inc.; Carl Zeiss Meditec AG; Elekta AB; Hologic Inc.; Mirion Technologies Inc.; Accuray Inc.; Eckert & Ziegler BEBIG S.A.; Theragenics Corporation; Sensus Healthcare Inc.; Aetna Inc.; CIVCO Medical Solutions; iCAD Inc.; IsoRay Inc.; BEBIG Medical GmbH; IsoAid L.L.C.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Brachytherapy Devices market report include:- Siemens Healthineers AG
- Becton Dickinson and Company
- GE HealthCare Technologies Inc.
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- Varian Medical Systems Inc.
- Carl Zeiss Meditec AG
- Elekta AB
- Hologic Inc.
- Mirion Technologies Inc.
- Accuray Inc.
- Eckert & Ziegler BEBIG S.A.
- Theragenics Corporation
- Sensus Healthcare Inc.
- Aetna Inc.
- CIVCO Medical Solutions
- iCAD Inc.
- IsoRay Inc.
- BEBIG Medical GmbH
- IsoAid L.L.C.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.85 Billion |
| Forecasted Market Value ( USD | $ 1.1 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
